NADAC acquisition cost data for COTEMPLA XR-ODT 17.3 MG TABLET. This is a brand-name medication — generic alternatives may be available at lower prices.
| Generic Name | Methylphenidate |
| Brand Name | Cotempla XR-ODT |
| Manufacturer | Neos Therapeutics Brands, LLC |
| Dosage Form | TABLET, ORALLY DISINTEGRATING |
| Route | ORAL |
| Pharmacologic Class | Central Nervous System Stimulant |
| Product Type | HUMAN PRESCRIPTION DRUG |
| DEA Schedule | CII |
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 70165020030 | $14.93 | 2022-10-01 | Rx |
| 70165020030 | $14.93 | 2022-10-01 | Rx |
| 70165020030 | $14.93 | 2022-10-01 | Rx |
| 70165020030 | $14.93 | 2022-10-01 | Rx |
| 70165020030 | $14.93 | 2022-10-01 | Rx |
| 70165020030 | $14.93 | 2022-10-01 | Rx |
| 70165020030 | $14.93 | 2022-10-01 | Rx |
| 70165020030 | $14.93 | 2022-10-01 | Rx |
| 70165020030 | $14.93 | 2022-10-01 | Rx |
| 70165020030 | $14.93 | 2022-10-01 | Rx |
Generic: Methylphenidate | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $58.8K | 98 | 24 | $12.46 |
| 2020 | $93.1K | 133 | 22 | $14.61 |
| 2021 | $102.5K | 160 | 21 | $15.65 |
| 2022 | $146.4K | 221 | 35 | $15.82 |
| 2023 | $237.3K | 294 | 55 | $16.89 |
These generic drugs may be equivalent alternatives at lower prices.
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.
Explore More Data Tools
For adjacent public-data tools, methodology notes, and network updates, visit DataPeek Facts.